Malawi's Request for Proposals is available here
Download ↓Malawi
- National Microbiology Reference Laboratory, Public Health Institute of Malawi (PHIM), Lilongwe | Active | Human health
- Kamuzu Central Hospital, Lilongwe | Active | Human health
- Central Veterinary Reference Laboratory, Lilongwe | Active | Veterinary
- Lilongwe Central Water Laboratory, Lilongwe | Active | Environmental
- Ministry of Agriculture (AMRCC, Epidemiology), Lilongwe | Active | Agriculture
- Ministry of Health (AMRCC, Epidemiology, NMRL), Lilongwe | Active | Human health
- Queen Elizabeth Central Hospital, Blantyre | Active | Human health
- Malamulo Adventist Hospital, Makwasa | Active | Human health
- Southern Regional Veterinary Laboratory, Blantyre | Active | Veterinary
- Zomba Central Hospital Laboratory, Zomba | Active | Human health
- Mzuzu Central Hosptial Laboratory, Mzuzu | Active | Human health
- Mzuzu Vertinary Laboratory, Mzuzu | Active | Veterinary
- Mzimba South District Hospital Laboratory, Mzimba | Active | Human health
- Mangochi District Hospital Laboratory, Mangochi | Active | Human health
- Chikwawa District Hospital, Chikwawa | Active | Human health
- Rumphi District Hospital, Rumphi | Active | Human health
AMR Governance Structure
Antimicrobial Resistance National Coordinating Committee including the Ministry of Health; Ministry of Agriculture, Irrigation and Water Development; and Ministry of Natural Resources, Energy and Mining.
AMR Action Plan
Malawi developed and implemented a Health Sector Strategic Plan I from 2011 to 2016, which was followed by the Health Sector Strategic Plan II (HSPII), running from 2017 to 2022. The plans were aimed at improving programme continuity within the health sector, and its overall contribution to national development. AMR was included in the HSSPII as a critical area of intervention and therefore provides a framework for the development of the national AMR strategy.
The Malawi AMR National Action Plan, published as the National AMR Strategy, ran from 2017-2022 and provides the operational detail to the HSSPII strategy outline, in response to the global WHO efforts to reduce the impact of AMR.
Latest Activity
Phase II of the Fleming Fund in Malawi means a further £3m of investment in laboratories, disease surveillance systems, and the workforc…
New country reports provide detailed accounts of drug resistance surveillance across the African continent to reduce the burden of AMR.